Tamar Berger

7PUBLICATIONS
14CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyAllergyImmunogenetics (incl. genetic immunology)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 19, 2023
Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma-a real-world multicenter retrospective cohort study.

Tamar Berger, Tzippy Shochat, Shlomzion Aumann

|Oct 07, 2022
Real-world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study.

Tamir Shragai, Hila Magen, Noa Lavi

|Sep 14, 2022
Effect of steroid treatment on the diagnostic yield of baseline 18f-fluorodeoxyglucose positron emission tomography in aggressive B cell lymphoma.

Karyn Revital Geiger, Oren Pasvolsky, Tamar Berger

|Sep 06, 2022
Infectious complications and long-term outcomes in patients with diffuse large B-Cell lymphoma and diabetes mellitus.

Oren Pasvolsky, Tamar Berger, Karyn Revital Geiger

|May 31, 2022
Repeat biopsy in relapsed or refractory diffuse large B cell lymphoma: a nationwide survey and retrospective study.

Tamar Berger, Karyn Revital Geiger, Moshe Yeshurun

|Jun 08, 2021
Skin biopsies in acute myeloid leukemia patients undergoing intensive chemotherapy are safe and effect patient management.

Tamar Berger, Shany Sherman, Lucille Hayman

Pageof 2

Frequent Collaborators

3 joint publications

Oren Pasvolsky

1 joint publications

Karyn Revital Geiger

1 joint publications

Tzippy Shochat

1 joint publications

Tamer Anati